Aspiriant LLC’s United States Oil Fund USO Stock Holding History

Aspiriant LLC’s Portfolio USO Stock Details USO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,892	Closed	-$1.22M	–	189
2016 Q3	$1.22M	Sell	13,892 -32,667	-70%	-$2.74M	0.12%	95
2016 Q2	$4.31M	Buy	+46,559	New	+$4.17M	0.41%	39
2015 Q4	–	Sell	-1,558	Closed	-$183K	–	96
2015 Q3	$183K	Buy	+1,558	New	+$191K	0.02%	104

Other funds holding USO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Exane Derivatives Paris, France $174M AUM 7.84% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Aspiriant LLC's USO Position: Q4 2016 in Review

Aspiriant LLC sold out of United States Oil Fund (USO) in Q4 2016, closing a stake of 13,892 shares — an estimated $1.22M sold.

Aspiriant LLC first reported a position in USO in Q3 2015 and held it in 3 quarters. The position peaked at $4.31M in Q2 2016. 180 funds tracked by Wall St. Rank hold USO as of Q4 2016.

Aspiriant LLC reported no remaining United States Oil Fund position as of Q4 2016 after selling out during the quarter.
Aspiriant LLC sold 13,892 United States Oil Fund shares in Q4 2016, an estimated $1.22M.
Aspiriant LLC first reported a position in United States Oil Fund in Q3 2015 and held it in 3 quarters.
Aspiriant LLC's United States Oil Fund position peaked at $4.31M in Q2 2016.
180 funds tracked by Wall St. Rank held United States Oil Fund as of Q4 2016.

Based on Aspiriant LLC's 13F filing for Q4 2016, filed 10 Feb 2017.